| Alexion Receives FDA Approval of Rhode Island Manufacturing Facility for ... - MarketWatch (press release) |
|
|
MarketWatch (press release)... Soliris as a treatment for patients with other severe and ultra-rare disorders are currently underway in areas that include nephrology and transplant. ... read more |